In vitro functional experiments in cell lines indicated that MEF2C functions as a transcriptional regulator, resulting in the activation of at least five genes highly expressed in immature T-ALL, namely PSCD4, HHEX, FAM46A, LMO2, and LYL1. This evidence concerns the gene LMO2 and acute lymphoblastic leukemia.